Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Phase II Study Of Sunitinib In Men With Advanced Prostate Cancer
UroToday.com - In the Annals of Oncology, Dr. Dror Michaelson and associates reported Phase II data on the efficacy and safety of the tyrosine kinase inhibitor sunitinib in patients with castration-resistant prostate cancer (CRPC). Sunitinib inhibits vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF), both elevated in prostate cancer (CaP).
generic viagra online
Groundbreaking New Guide For Patients With Secondary Breast Cancer
The UK"s first guide to help secondary breast cancer1 patients struggling to access necessary levels of support and care has been launched today.
News of the day
HHS Rescinds Medicaid Regulations
Department of Health and Human Services (HHS) Secretary Kathleen Sebelius announced that the administration will rescind all or part of three Medicaid regulations that were previously issued and delay the enforcement of a fourth regulation. Each of these rules, in whole or in part, had been subject to Congressional moratoria set to expire on July 1, 2009.
Oncology

British Medical Journal Group Provides Medical Information For Doctors On The Move

Health professionals across the world can now get on-the-spot access to expert opinion, guidelines and the latest clinical evidence on their mobile phone. This service is being made available at no extra cost to all subscribers of Best Practice, the new on-line decision support tool designed to help practitioners, medical students and researchers find the best medical information and use it in the most effective way. Built specifically for point-of-care use it helps meet the real, diverse and evolving information challenges that health professionals face every day whether in the surgery, hospital or out in the community. "For doctors on the move, having immediate access to reliable information is a real bonus for busy clinicians seeking to deliver evidence-based health care", says Dr Charles Young, Best Practice Editor in Chief. "Doctors now have a reliable second opinion in an instant - anywhere, anytime." This facility has been made possible through a joint agreement with Mobile IQ, enabling the BMJ Group to benefit from Mobile IQ"s award winning mobile publishing platform, Fabric. This allows access to any content contained in Best Practice on any mobile device and the information is fully searchable to ensure easy navigation of the material. Fabric also supports links between mobile devices and e-mails so that, for example, doctors who find an interesting article whilst on the phone can email it to themselves and read it later at their desk. "Mobile IQ is delighted to be powering the BMJ Group"s mobile strategy, enabling them to rapidly deliver their content in new and innovative ways," said Shaun Barriball, Managing Director of Mobile IQ. "This partnership demonstrates that mobile is maturing and being embraced by enterprises to deliver critical information." Best Practice covers 10,000 diagnoses and all content is written and peer reviewed by internationally renowned specialists. It provides critical prescribing information, guideline summaries and expert opinion together with advice on symptom evaluation, test ordering and treatment strategies. Best Practice Mobile is at: http://bp.bmjgroup.mobi British Medical Journal


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009